|
| 生存变量 |
数目 |
2年 |
5年 |
10年 |
传值 |
|
| 整体性 |
24码 |
33% |
27% |
9% |
|
|
| 时间回击 |
|
|
|
|
|
| 12个月 |
11 |
77% |
39% |
19% |
0.0060
|
| <12个月 |
13 |
30% |
0% |
0% |
| 外科剖析程度 |
|
|
|
|
|
| 完全化 |
16 |
53% |
42% |
16% |
.004 |
| R1/R2 |
8 |
12% |
0% |
0% |
| FIGO诊断阶段 |
|
|
|
|
|
| 一 |
14 |
47% |
47% |
16% |
0.010 |
| II/III/IV |
10 |
12% |
0% |
0% |
| 1肿瘤对2 |
|
|
|
|
|
| 1肿瘤 |
12 |
81% |
51% |
26% |
0.015 |
| 2肿瘤 |
12 |
33% |
0% |
0% |
| 等级划分 |
|
|
|
|
|
| 低频 |
4 |
50% |
50% |
25% |
0.140 |
| 高位 |
21号 |
29% |
22% |
11% |
| 程序类型 |
|
|
|
|
|
| 仅染色体 |
20码 |
75% |
75% |
75% |
0.890 |
| 非thorac |
4 |
26% |
0% |
0% |
| 局部复发 |
|
|
|
|
|
| 本地化 |
8 |
63% |
25% |
0% |
0.600 |
| 远端 |
16 |
56% |
25% |
13% |
| 初始dx后Adjivant理疗 |
|
|
|
|
|
| 无 |
12 |
58% |
20% |
20% |
0.425 |
| CT和/或RT |
12 |
58% |
25% |
0% |
| 复发后Adjivant理疗 |
|
|
|
|
|
| 无 |
10 |
50% |
36% |
18% |
0.565 |
| CT和/或RT |
14 |
70% |
13% |
13% |
|
|
